Pumpkin Seed Oil Extract for Overactive Bladder Symptoms
Pumpkin Seed Extract
Urogenital Diseases+8
+ Urinary Bladder Diseases
+ Female Urogenital Diseases and Pregnancy Complications
Supportive Care Study
Summary
Study start date: April 11, 2025
Actual date on which the first participant was enrolled.This study is exploring the effects of pumpkin seed oil extract on bladder function, particularly for those experiencing overactive bladder (OAB) symptoms like frequent and urgent trips to the bathroom. The research focuses on individuals seeking natural or conservative management methods for their bladder health, especially since traditional treatments often come with unwanted side effects and the exact cause of OAB is not fully understood. By studying the impact of pumpkin seed oil, which has shown promise in other small studies, this research aims to provide more evidence on its effectiveness and safety for a diverse U.S. patient population. Participants in this study will take one pill of pumpkin seed oil extract daily for 12 weeks. Their bladder function will be monitored through questionnaires completed at the start, 4 weeks, and 12 weeks into the study. These surveys will help assess changes in bladder symptoms, pelvic floor control, and willingness to continue using the supplement. The study also looks at whether participants have used other alternative medicines in the past. Participants are advised not to start any new medications or share their supplements during the trial period. The research ensures the confidentiality of participant data, which will be securely stored and later analyzed to understand the potential benefits of pumpkin seed oil extract.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.40 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location